ACER3: Alkaline Ceramidase 3

A key regulator of sphingolipid metabolism involved in leukodystrophy and cancer

Gene Information Card

Symbol ACER3
Full Name Alkaline Ceramidase 3
Gene Type Protein coding
Chromosomal Location 11q13.5
NCBI Gene ID 55331 ncbi.nlm.nih.gov/gene/55331
Ensembl ID ENSG00000149131
UniProt ID Q9H7Z7
OMIM ID 617105
HGNC ID 16066
Aliases PHCA, ALKCDase3, APHC, ASAH3L

Description

ACER3 encodes alkaline ceramidase 3, a membrane-bound enzyme that catalyzes the hydrolysis of ceramide into sphingosine and free fatty acids, preferentially acting on unsaturated long-chain ceramides (C18:1, C20:1, C20:4). It plays a critical role in sphingolipid homeostasis, cell signaling, and apoptosis. Mutations in ACER3 cause leukodystrophy, and altered expression is implicated in various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Leukodystrophy, progressive, with leukoencephalopathy and developmental delay Loss-of-function mutations impair ceramide hydrolysis, leading to accumulation of unsaturated ceramides and disruption of myelin maintenance OMIM #617105, ClinVar
Hepatocellular carcinoma Overexpression of ACER3 promotes cell proliferation and resistance to apoptosis via altered sphingolipid signaling COSMIC, PubMed studies
Colorectal cancer Upregulation associated with poor prognosis; modulates ceramide/sphingosine-1-phosphate balance COSMIC, PubMed studies

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 8.2 Medium
Liver 6.5 Medium
Kidney 5.1 Low
Lung 4.3 Low
Heart 3.8 Low
Testis 2.9 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 7.1 Hepatocellular carcinoma cell line
A549 5.4 Lung adenocarcinoma cell line
HEK293 4.8 Embryonic kidney cells
SH-SY5Y 6.2 Neuroblastoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.103C>T (p.Arg35Ter) Nonsense Rare Loss of function; associated with leukodystrophy
c.200T>C (p.Leu67Pro) Missense Rare Loss of function; reduced ceramidase activity
c.487G>A (p.Gly163Arg) Missense Rare Loss of function; impaired protein stability
Mutation functional classification

Loss of Function (LOF)

Nonsense and missense mutations (e.g., p.Arg35Ter, p.Leu67Pro) reduce or abolish enzymatic activity, leading to ceramide accumulation and leukodystrophy.

Gain of Function (GOF)

Not reported in germline; overexpression in cancers may confer gain-of-function through increased sphingosine-1-phosphate production.

Dominant Negative (DN)

Not documented for ACER3.

Gene Ontology (GO)

• GO:0017040 - ceramidase activity • GO:0046513 - ceramide metabolic process
• GO:0006672 - ceramide biosynthetic process • GO:0016021 - integral component of membrane
• GO:0005783 - endoplasmic reticulum

Pathways

Sphingolipid metabolism (Reactome: R-HSA-428157)
Sphingosine-1-phosphate signaling (Reactome: R-HSA-428930)

Protein Summary

Alkaline ceramidase 3 (ACER3) is a 297-amino acid integral membrane protein localized to the endoplasmic reticulum. It catalyzes the hydrolysis of ceramide to sphingosine, with a preference for unsaturated long-chain ceramides. The enzyme is involved in regulating cellular levels of bioactive sphingolipids, influencing cell survival, proliferation, and differentiation. ACER3 is expressed in brain, liver, and kidney, and its dysfunction is linked to neurological disorders and cancer.

Related Products

Product name Cat.No. Species Gene ID
ACER3 Knockout HEK293 Cell Line EDJ-KQ2859 Human 55331 Details Get a Quote
ACER3 Knockout A-549 Cell Line EDJ-KQ23880 Human 55331 Details Get a Quote
ACER3 Knockout HCT 116 Cell Line EDJ-KQ23881 Human 55331 Details Get a Quote
ACER3 Knockout HeLa Cell Line EDJ-KQ23882 Human 55331 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: